![Anatomy / Immunomodulation therapy / Immunotherapy / Immunosuppressive drug / Autoimmunity / Monoclonal antibodies / Ulcerative colitis / Immune system / Rheumatoid arthritis / Medicine / Immunology / Health Anatomy / Immunomodulation therapy / Immunotherapy / Immunosuppressive drug / Autoimmunity / Monoclonal antibodies / Ulcerative colitis / Immune system / Rheumatoid arthritis / Medicine / Immunology / Health](https://www.pdfsearch.io/img/6c95f929b5a27dfa318eb86f47a22dff.jpg)
| Document Date: 2015-03-26 10:59:05 Open Document File Size: 125,01 KBShare Result on Facebook
Company Janssen Biotech Investment Attractiveness / Janssen Biotech / DEBIOPHARM DIAGNOSTICS / / Currency USD / EUR / / / Event FDA Phase / / Facility Effimune pipeline / / IndustryTerm biological products / biotechnology / upstream product / prescription products / pharmaceutical / upstream products / / MedicalCondition Immune dysfunction / burn / cancer / rheumatoid arthritis / ulcerative colitis / autoimmune disease / / MedicalTreatment immunotherapy / / Person Jean-Paul Soulillou / Michel Goldman / / / Position HIANCE Maryvonne Chairman VANHOVE Bernard CEO AUTRET-CORNET Anne-Laure Financial Manager / Chairman / Professor / IP Manager / / Product FR104 / / Technology alpha / antibodies / biotechnology / transplantation / / URL www.effimune.com / /
SocialTag |